Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir
- 1 February 2010
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 39 (4), 203-212
- https://doi.org/10.1016/j.ejps.2009.11.007
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase InhibitorAntimicrobial Agents and Chemotherapy, 2009
- The study of different solid forms of EmodepsideEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir GelPLoS Medicine, 2008
- Pharmaceutical Applications of Hot-Melt Extrusion: Part IDrug Development and Industrial Pharmacy, 2007
- In vivo assessment of NuvaRing® placementContraception, 2005
- Regulatory Challenges in Microbicide DevelopmentScience, 2004
- Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 VariantsJournal of Medicinal Chemistry, 2004
- Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulationAIDS, 2003
- Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ringObstetrics & Gynecology, 2002
- Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ringEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1993